Abstract |
During the last few years, HLA class I tetramers have been successfully used to demonstrate anti- vaccine CD8 CTL proliferation in cancer patients vaccinated with tumor antigens. Frequencies of CTL as low as 10(-6) among CD8 cells were observed even in patients showing tumor regression. Little is known about the role of tumor-antigen-specific CD4 T cells in the context of these anti- vaccine responses. Therefore, we developed a very sensitive approach using fluorescent class-II- peptide multimers to detect antigen-specific CD4 T cells in vaccinated cancer patients. We produced HLA-DP4 multimers loaded with the MAGE-3(243-258) peptide and used them to stain ex vivo PBL from melanoma patients injected with dendritic cells pulsed with several class I and class II tumor antigenic peptides, including the MAGE-3(243-258) peptide. The multimer(+) CD4 T cells were sorted and amplified in clonal conditions; specificity was assessed by their ability to secrete IFN-gamma upon contact with the MAGE-3 antigen. We detected frequencies of about 1x10(-6) anti-MAGE-3.DP4 cells among CD4 cells. A detailed analysis of one patient showed an anti-MAGE-3.DP4 CD4 T cell amplification of at least 3000-fold upon immunization. TCR analysis of the clones from this patient demonstrated a polyclonal response against the MAGE-3 peptide.
|
Authors | Yi Zhang, Nicolina Renkvist, Zhaojun Sun, Beatrice Schuler-Thurner, Nicolas Glaichenhaus, Gerold Schuler, Thierry Boon, Pierre van der Bruggen, Didier Colau |
Journal | European journal of immunology
(Eur J Immunol)
Vol. 35
Issue 4
Pg. 1066-75
(Apr 2005)
ISSN: 0014-2980 [Print] Germany |
PMID | 15756643
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antibodies, Neoplasm
- Antigens, Neoplasm
- Cancer Vaccines
- Epitopes, T-Lymphocyte
- HLA-DP Antigens
- HLA-DP beta-Chains
- HLA-DPw4 antigen
- MAGEA3 protein, human
- Neoplasm Proteins
- Peptide Fragments
- Biotin
|
Topics |
- Antibodies, Neoplasm
(immunology)
- Antigen Presentation
- Antigens, Neoplasm
(immunology, metabolism)
- Biotin
- CD4-Positive T-Lymphocytes
(immunology)
- Cancer Vaccines
- Dendritic Cells
(immunology, transplantation)
- Epitopes, T-Lymphocyte
(immunology)
- HLA-DP Antigens
(immunology, metabolism)
- HLA-DP beta-Chains
- Humans
- Immunotherapy, Adoptive
- Melanoma
(immunology, therapy)
- Neoplasm Proteins
(immunology, metabolism)
- Peptide Fragments
(immunology, metabolism)
- Vaccination
|